| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 43 | 2024 | 363 | 8.690 |
Why?
|
| Fontan Procedure | 14 | 2024 | 56 | 2.800 |
Why?
|
| Cardiac Surgical Procedures | 14 | 2022 | 475 | 2.180 |
Why?
|
| Tetralogy of Fallot | 10 | 2017 | 44 | 1.960 |
Why?
|
| Heart Valve Prosthesis Implantation | 6 | 2017 | 178 | 1.470 |
Why?
|
| Genetic Testing | 4 | 2020 | 537 | 1.450 |
Why?
|
| Pulmonary Valve | 5 | 2018 | 34 | 1.300 |
Why?
|
| Lung Diseases | 3 | 2018 | 269 | 1.270 |
Why?
|
| Postoperative Complications | 12 | 2023 | 2275 | 1.080 |
Why?
|
| Prevalence | 18 | 2020 | 1240 | 0.950 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2014 | 109 | 0.790 |
Why?
|
| Risk Factors | 19 | 2020 | 5466 | 0.770 |
Why?
|
| Retrospective Studies | 31 | 2024 | 9003 | 0.750 |
Why?
|
| Adult | 48 | 2023 | 26508 | 0.700 |
Why?
|
| Heterotaxy Syndrome | 1 | 2019 | 2 | 0.700 |
Why?
|
| Follow-Up Studies | 19 | 2019 | 3657 | 0.700 |
Why?
|
| Postoperative Care | 3 | 2018 | 229 | 0.690 |
Why?
|
| Young Adult | 28 | 2020 | 6289 | 0.670 |
Why?
|
| Rare Diseases | 1 | 2019 | 65 | 0.670 |
Why?
|
| Adolescent | 27 | 2023 | 9237 | 0.660 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2012 | 67 | 0.650 |
Why?
|
| Humans | 74 | 2024 | 89073 | 0.630 |
Why?
|
| Patient Care Management | 1 | 2018 | 30 | 0.620 |
Why?
|
| Child, Preschool | 15 | 2020 | 3717 | 0.610 |
Why?
|
| Pulmonary Valve Insufficiency | 2 | 2015 | 12 | 0.600 |
Why?
|
| Program Evaluation | 1 | 2019 | 306 | 0.600 |
Why?
|
| Liver Cirrhosis | 3 | 2016 | 254 | 0.600 |
Why?
|
| Infant | 12 | 2019 | 3147 | 0.590 |
Why?
|
| Male | 50 | 2020 | 42254 | 0.590 |
Why?
|
| Female | 51 | 2020 | 46014 | 0.580 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 216 | 0.560 |
Why?
|
| Aortic Aneurysm | 3 | 2014 | 80 | 0.550 |
Why?
|
| Liver Diseases | 3 | 2023 | 242 | 0.550 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2012 | 346 | 0.540 |
Why?
|
| Inpatients | 1 | 2019 | 310 | 0.540 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 145 | 0.530 |
Why?
|
| Preoperative Care | 1 | 2018 | 396 | 0.530 |
Why?
|
| Quality of Life | 4 | 2022 | 1662 | 0.530 |
Why?
|
| Aorta | 2 | 2014 | 288 | 0.520 |
Why?
|
| Risk Assessment | 9 | 2018 | 2291 | 0.500 |
Why?
|
| Aortic Coarctation | 2 | 2012 | 36 | 0.490 |
Why?
|
| Time Factors | 13 | 2019 | 5320 | 0.490 |
Why?
|
| Child | 20 | 2020 | 7149 | 0.480 |
Why?
|
| Marfan Syndrome | 1 | 2014 | 28 | 0.470 |
Why?
|
| Treatment Outcome | 17 | 2019 | 8203 | 0.460 |
Why?
|
| Exercise Tolerance | 2 | 2014 | 53 | 0.450 |
Why?
|
| Polyethylene Terephthalates | 2 | 2012 | 18 | 0.440 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2015 | 113 | 0.440 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2015 | 132 | 0.430 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2015 | 192 | 0.430 |
Why?
|
| Transposition of Great Vessels | 1 | 2012 | 24 | 0.430 |
Why?
|
| Wisconsin | 7 | 2019 | 41 | 0.420 |
Why?
|
| Hepatitis C | 1 | 2014 | 170 | 0.420 |
Why?
|
| Infant, Newborn | 9 | 2020 | 2476 | 0.410 |
Why?
|
| Interleukin-18 | 1 | 2012 | 26 | 0.410 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2012 | 70 | 0.410 |
Why?
|
| Lipocalins | 1 | 2012 | 35 | 0.410 |
Why?
|
| Acute-Phase Proteins | 1 | 2012 | 37 | 0.410 |
Why?
|
| Ventricular Remodeling | 1 | 2012 | 105 | 0.400 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2013 | 329 | 0.400 |
Why?
|
| Surgical Procedures, Operative | 2 | 2013 | 205 | 0.400 |
Why?
|
| Tomography, Spiral Computed | 1 | 2012 | 77 | 0.390 |
Why?
|
| Pulmonary Veins | 1 | 2012 | 93 | 0.390 |
Why?
|
| Predictive Value of Tests | 8 | 2019 | 1715 | 0.380 |
Why?
|
| Creatinine | 1 | 2012 | 293 | 0.380 |
Why?
|
| Liver | 2 | 2016 | 1205 | 0.380 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2012 | 89 | 0.380 |
Why?
|
| Lung | 3 | 2017 | 1258 | 0.380 |
Why?
|
| Vena Cava, Inferior | 1 | 2012 | 145 | 0.370 |
Why?
|
| Health Status | 2 | 2012 | 370 | 0.360 |
Why?
|
| Comorbidity | 4 | 2020 | 948 | 0.360 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2012 | 242 | 0.360 |
Why?
|
| Heart Valve Diseases | 3 | 2017 | 115 | 0.350 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 2335 | 0.340 |
Why?
|
| Exercise Test | 7 | 2017 | 165 | 0.340 |
Why?
|
| Middle Aged | 21 | 2020 | 25865 | 0.330 |
Why?
|
| Mitral Valve | 2 | 2017 | 262 | 0.320 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2012 | 41 | 0.310 |
Why?
|
| Data Collection | 3 | 2015 | 375 | 0.310 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 665 | 0.310 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 311 | 0.300 |
Why?
|
| Heart Transplantation | 2 | 2023 | 717 | 0.300 |
Why?
|
| Prognosis | 7 | 2016 | 3773 | 0.290 |
Why?
|
| Kidney | 1 | 2012 | 1145 | 0.280 |
Why?
|
| Pulmonary Atresia | 3 | 2012 | 12 | 0.280 |
Why?
|
| Spirometry | 4 | 2017 | 68 | 0.280 |
Why?
|
| Exercise | 3 | 2016 | 322 | 0.270 |
Why?
|
| Liver Transplantation | 2 | 2023 | 1177 | 0.260 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2005 | 18 | 0.260 |
Why?
|
| Age Factors | 7 | 2019 | 1867 | 0.250 |
Why?
|
| Surveys and Questionnaires | 6 | 2020 | 2612 | 0.250 |
Why?
|
| Catheterization | 1 | 2005 | 237 | 0.230 |
Why?
|
| Balloon Occlusion | 1 | 2004 | 29 | 0.230 |
Why?
|
| Tropomyosin | 1 | 2003 | 16 | 0.220 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2003 | 42 | 0.210 |
Why?
|
| Cardiac Rehabilitation | 1 | 2022 | 5 | 0.210 |
Why?
|
| Dilatation, Pathologic | 4 | 2015 | 55 | 0.200 |
Why?
|
| Abnormalities, Multiple | 1 | 2003 | 234 | 0.200 |
Why?
|
| Cross-Sectional Studies | 10 | 2018 | 1706 | 0.200 |
Why?
|
| Aortic Valve | 2 | 2015 | 243 | 0.200 |
Why?
|
| Databases, Factual | 2 | 2015 | 850 | 0.190 |
Why?
|
| Survivors | 2 | 2024 | 233 | 0.190 |
Why?
|
| Morbidity | 3 | 2023 | 149 | 0.190 |
Why?
|
| Glomerular Filtration Rate | 2 | 2012 | 275 | 0.190 |
Why?
|
| Obesity | 2 | 2020 | 966 | 0.190 |
Why?
|
| Multivariate Analysis | 4 | 2015 | 988 | 0.180 |
Why?
|
| Reoperation | 3 | 2015 | 598 | 0.180 |
Why?
|
| Bioprosthesis | 2 | 2018 | 39 | 0.180 |
Why?
|
| Disease Management | 3 | 2017 | 329 | 0.180 |
Why?
|
| Ebstein Anomaly | 1 | 2020 | 5 | 0.180 |
Why?
|
| Aged | 8 | 2020 | 19078 | 0.180 |
Why?
|
| Odds Ratio | 3 | 2015 | 684 | 0.170 |
Why?
|
| Patient Education as Topic | 2 | 2013 | 359 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 390 | 0.170 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 46 | 0.170 |
Why?
|
| Severity of Illness Index | 5 | 2019 | 1837 | 0.170 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2018 | 5 | 0.160 |
Why?
|
| Neonatal Screening | 1 | 2019 | 62 | 0.160 |
Why?
|
| Diastole | 2 | 2013 | 141 | 0.160 |
Why?
|
| Endocarditis, Bacterial | 1 | 2018 | 38 | 0.160 |
Why?
|
| Coronary Angiography | 1 | 2019 | 242 | 0.150 |
Why?
|
| Respiratory Function Tests | 1 | 2018 | 139 | 0.150 |
Why?
|
| Prosthesis-Related Infections | 1 | 2018 | 60 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2015 | 197 | 0.150 |
Why?
|
| Heart Septal Defects | 2 | 2015 | 32 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 146 | 0.150 |
Why?
|
| Vascular Surgical Procedures | 2 | 2012 | 149 | 0.150 |
Why?
|
| Cardiac Catheterization | 1 | 2019 | 302 | 0.150 |
Why?
|
| Biomarkers | 3 | 2016 | 1755 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 754 | 0.150 |
Why?
|
| Karyotype | 1 | 2017 | 34 | 0.150 |
Why?
|
| Mucopolysaccharidosis I | 1 | 2017 | 2 | 0.150 |
Why?
|
| Analysis of Variance | 2 | 2012 | 901 | 0.150 |
Why?
|
| Echocardiography | 4 | 2017 | 937 | 0.150 |
Why?
|
| American Heart Association | 1 | 2017 | 94 | 0.140 |
Why?
|
| Prospective Studies | 6 | 2023 | 4273 | 0.140 |
Why?
|
| Vital Capacity | 1 | 2017 | 68 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 153 | 0.140 |
Why?
|
| Pregnancy Outcome | 2 | 2011 | 253 | 0.140 |
Why?
|
| Self Report | 1 | 2018 | 295 | 0.140 |
Why?
|
| Biomedical Research | 2 | 2013 | 398 | 0.140 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2016 | 35 | 0.140 |
Why?
|
| Cognition Disorders | 1 | 2018 | 235 | 0.140 |
Why?
|
| Hyaluronic Acid | 1 | 2016 | 49 | 0.130 |
Why?
|
| Statistics, Nonparametric | 2 | 2016 | 306 | 0.130 |
Why?
|
| Atrial Fibrillation | 3 | 2012 | 350 | 0.130 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2016 | 69 | 0.130 |
Why?
|
| Sinus of Valsalva | 2 | 2012 | 18 | 0.130 |
Why?
|
| Diagnostic Imaging | 3 | 2015 | 479 | 0.130 |
Why?
|
| Atrial Flutter | 2 | 2012 | 35 | 0.130 |
Why?
|
| Heart Failure | 2 | 2023 | 1180 | 0.130 |
Why?
|
| Exercise Therapy | 1 | 2016 | 81 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1591 | 0.130 |
Why?
|
| Cyanosis | 1 | 2015 | 9 | 0.130 |
Why?
|
| Paraganglioma | 1 | 2015 | 16 | 0.120 |
Why?
|
| Pregnancy | 3 | 2014 | 3010 | 0.120 |
Why?
|
| Home Care Services | 1 | 2016 | 73 | 0.120 |
Why?
|
| Survival Rate | 3 | 2017 | 1889 | 0.120 |
Why?
|
| Echocardiography, Doppler | 2 | 2013 | 186 | 0.120 |
Why?
|
| Transfusion Reaction | 1 | 2014 | 17 | 0.120 |
Why?
|
| Automation | 1 | 2015 | 111 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 2 | 2015 | 352 | 0.120 |
Why?
|
| Aortic Diseases | 2 | 2012 | 100 | 0.120 |
Why?
|
| Preconception Care | 1 | 2014 | 7 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 362 | 0.120 |
Why?
|
| Pheochromocytoma | 1 | 2015 | 49 | 0.120 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2014 | 10 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2023 | 2863 | 0.120 |
Why?
|
| United States | 7 | 2017 | 6957 | 0.120 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2014 | 28 | 0.120 |
Why?
|
| Obstetric Labor Complications | 1 | 2014 | 34 | 0.120 |
Why?
|
| Postnatal Care | 1 | 2014 | 27 | 0.120 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2015 | 81 | 0.120 |
Why?
|
| Anesthesia, Epidural | 1 | 2014 | 32 | 0.120 |
Why?
|
| Clinical Protocols | 1 | 2014 | 157 | 0.120 |
Why?
|
| Hypertension | 1 | 2020 | 741 | 0.120 |
Why?
|
| Respiration Disorders | 1 | 2014 | 41 | 0.110 |
Why?
|
| Genome, Human | 1 | 2018 | 767 | 0.110 |
Why?
|
| Delivery, Obstetric | 1 | 2014 | 118 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 105 | 0.110 |
Why?
|
| Cognition | 1 | 2018 | 580 | 0.110 |
Why?
|
| Cardiac Care Facilities | 1 | 2013 | 2 | 0.110 |
Why?
|
| Survival Analysis | 3 | 2006 | 1533 | 0.110 |
Why?
|
| Incidence | 2 | 2018 | 1592 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 859 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 848 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 657 | 0.110 |
Why?
|
| Phenotype | 1 | 2019 | 2439 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2013 | 865 | 0.100 |
Why?
|
| Hospital Mortality | 1 | 2015 | 386 | 0.100 |
Why?
|
| Counseling | 1 | 2014 | 163 | 0.100 |
Why?
|
| Logistic Models | 2 | 2015 | 1212 | 0.100 |
Why?
|
| Lipocalin-2 | 1 | 2012 | 37 | 0.100 |
Why?
|
| Biopsy | 2 | 2016 | 1182 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 1214 | 0.100 |
Why?
|
| Preoperative Period | 1 | 2012 | 94 | 0.100 |
Why?
|
| Foreign Bodies | 1 | 2012 | 66 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2014 | 283 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2012 | 125 | 0.100 |
Why?
|
| Hospitals, Pediatric | 1 | 2012 | 115 | 0.100 |
Why?
|
| Mutation | 1 | 2003 | 4132 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2015 | 341 | 0.100 |
Why?
|
| Liver Circulation | 1 | 2011 | 29 | 0.100 |
Why?
|
| Continuity of Patient Care | 1 | 2013 | 172 | 0.100 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2013 | 136 | 0.090 |
Why?
|
| Pulmonary Circulation | 1 | 2011 | 90 | 0.090 |
Why?
|
| Patient Participation | 1 | 2013 | 224 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 1670 | 0.090 |
Why?
|
| Coronary Artery Bypass | 2 | 2019 | 234 | 0.090 |
Why?
|
| Venous Insufficiency | 1 | 2010 | 12 | 0.090 |
Why?
|
| Cutis Laxa | 1 | 2010 | 4 | 0.090 |
Why?
|
| Catheter Ablation | 1 | 2012 | 252 | 0.090 |
Why?
|
| Palliative Care | 1 | 2012 | 263 | 0.090 |
Why?
|
| Stroke Volume | 1 | 2012 | 462 | 0.090 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 319 | 0.090 |
Why?
|
| Mass Screening | 1 | 2014 | 636 | 0.090 |
Why?
|
| Pacemaker, Artificial | 1 | 2010 | 94 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2010 | 127 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2012 | 727 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 373 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2012 | 219 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 531 | 0.080 |
Why?
|
| Heart Rate | 1 | 2011 | 493 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2008 | 155 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 321 | 0.080 |
Why?
|
| Chest Pain | 1 | 2008 | 42 | 0.080 |
Why?
|
| Long QT Syndrome | 1 | 2007 | 36 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2011 | 729 | 0.070 |
Why?
|
| Anesthesia | 1 | 2009 | 169 | 0.070 |
Why?
|
| Liver Function Tests | 2 | 2016 | 92 | 0.070 |
Why?
|
| Cardiovascular Diseases | 2 | 2010 | 705 | 0.070 |
Why?
|
| Physicians | 1 | 2013 | 689 | 0.070 |
Why?
|
| Pregnancy, High-Risk | 1 | 2005 | 16 | 0.070 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2008 | 226 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 433 | 0.060 |
Why?
|
| Prenatal Care | 1 | 2005 | 77 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 433 | 0.060 |
Why?
|
| Genetic Counseling | 2 | 2015 | 101 | 0.060 |
Why?
|
| Medical Records | 1 | 2005 | 120 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 2657 | 0.060 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2004 | 16 | 0.060 |
Why?
|
| Heart Aneurysm | 1 | 2004 | 22 | 0.060 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2004 | 23 | 0.060 |
Why?
|
| Heart Murmurs | 1 | 2003 | 6 | 0.060 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2004 | 103 | 0.060 |
Why?
|
| Heart Valve Prosthesis | 2 | 2015 | 97 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2003 | 273 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 559 | 0.050 |
Why?
|
| Heart Atria | 1 | 2004 | 281 | 0.050 |
Why?
|
| Radiography | 1 | 2003 | 809 | 0.050 |
Why?
|
| Registries | 1 | 2005 | 778 | 0.050 |
Why?
|
| Cullin Proteins | 1 | 2020 | 8 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2024 | 1855 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2010 | 3374 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 6777 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2003 | 779 | 0.040 |
Why?
|
| Pedigree | 1 | 2020 | 969 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2012 | 711 | 0.040 |
Why?
|
| Binding Sites | 1 | 2020 | 1117 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 124 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2016 | 171 | 0.030 |
Why?
|
| Reproductive Health | 1 | 2016 | 34 | 0.030 |
Why?
|
| Age Distribution | 1 | 2016 | 200 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 505 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 301 | 0.030 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2015 | 7 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1487 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 360 | 0.030 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2015 | 14 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 233 | 0.030 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2015 | 31 | 0.030 |
Why?
|
| Vascular Grafting | 1 | 2015 | 16 | 0.030 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2015 | 59 | 0.030 |
Why?
|
| Cardiovascular Agents | 1 | 2015 | 54 | 0.030 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2015 | 12 | 0.030 |
Why?
|
| Clinical Coding | 1 | 2015 | 24 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2015 | 32 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2017 | 319 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2015 | 279 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2015 | 296 | 0.030 |
Why?
|
| Attention | 1 | 2018 | 394 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 1 | 2015 | 143 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2013 | 112 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 352 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 181 | 0.030 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2012 | 69 | 0.030 |
Why?
|
| Pericardium | 1 | 2012 | 70 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2012 | 98 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1796 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2012 | 299 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1710 | 0.020 |
Why?
|
| Length of Stay | 1 | 2015 | 732 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2015 | 771 | 0.020 |
Why?
|
| Lung Transplantation | 1 | 2015 | 290 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2013 | 298 | 0.020 |
Why?
|
| Elastic Tissue | 1 | 2010 | 18 | 0.020 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2010 | 23 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2010 | 51 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 243 | 0.020 |
Why?
|
| Leg | 1 | 2010 | 140 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2012 | 493 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1067 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2752 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2010 | 124 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2010 | 217 | 0.020 |
Why?
|
| Anesthetics | 1 | 2009 | 53 | 0.020 |
Why?
|
| Aortography | 1 | 2008 | 65 | 0.020 |
Why?
|
| Observer Variation | 1 | 2010 | 610 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2010 | 277 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2008 | 64 | 0.020 |
Why?
|
| Patient Selection | 1 | 2012 | 682 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2009 | 188 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2008 | 157 | 0.020 |
Why?
|
| Hyperemia | 1 | 2007 | 19 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2009 | 169 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2010 | 250 | 0.020 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2007 | 61 | 0.020 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2006 | 6 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2007 | 94 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 948 | 0.020 |
Why?
|
| Situs Inversus | 1 | 2006 | 15 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2008 | 321 | 0.020 |
Why?
|
| Skin | 1 | 2010 | 581 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2006 | 120 | 0.020 |
Why?
|
| Syndrome | 1 | 2006 | 449 | 0.020 |
Why?
|
| Spleen | 1 | 2006 | 432 | 0.020 |
Why?
|